Eric Moore, M.D., elected to Mayo Clinic Board of Trustees

Eric Moore, M.D., medical director of Mayo Clinic International, has been elected as the newest member of the Mayo Clinic Board of Trustees.

2026-02-26

(Press-News.org) JACKSONVILLE, Florida — Eric Moore, M.D., medical director of Mayo Clinic International and chair of the Department of Otolaryngology in Rochester, was elected to the Mayo Clinic Board of Trustees at its quarterly meeting on Feb. 20.

"Dr. Moore is an internationally respected leader whose commitment to patients and strategic vision will be a tremendous asset to our Board of Trustees," says Gianrico Farrugia, M.D., president and CEO, Mayo Clinic. “His extensive experience and collaborative approach will help guide our strategic priorities and strengthen Mayo Clinic’s impact for patients worldwide."

Dr. Moore was appointed medical director of Mayo Clinic International in April 2025. A professor and chair of the Department of Otolaryngology at Mayo Clinic in Rochester, Dr. Moore has more than 30 years of experience in head and neck surgery. As department chair, Dr. Moore leads Mayo Clinic's care for patients with complex ear, nose and throat (ENT) conditions while advancing excellence in clinical care, education and research. His joint appointments in the division of Oral and Maxillofacial Surgery in the department of General Surgery, Neurosurgery and Pediatrics ensure better-coordinated treatments for ENT patients.

Dr. Moore attended medical school at Jefferson Medical College, completed his residency in otolaryngology-head and neck surgery at Mayo Clinic from 1992 to 1997 and pursued a fellowship in endoscopic skull base surgery in Graz, Austria, in 2001. He also served as a major in the United States Air Force from 1997 to 2001 before beginning his clinical practice in head and neck surgery at Mayo Clinic.

Dr. Moore is a pioneer in less invasive transoral robotic surgery and has improved outcomes for patients with head and neck cancers. A dedicated mentor, he has contributed extensively to otolaryngology education and has received multiple awards, including the Mayo Fellows Teacher of the Year Award five times.

Reelected, emeritus trustees

The Mayo Clinic Board of Trustees reelected two trustees:

Matthew Callstrom, M.D., Ph.D., has been a consultant at Mayo Clinic since 2000 and holds the academic rank of professor of radiology. He serves as medical director for the Strategy Department and the Artificial Intelligence Program as well as associate medical director in the Department of Development.

Abimbola Famuyide, M.B.B.S., is a professor of obstetrics and gynecology at Mayo Clinic in Rochester and has been a consultant at Mayo Clinic for over 22 years. He currently serves as chair of the Mayo Clinic in Rochester Personnel Committee. His areas of interest include research in abnormal uterine bleeding, benign gynecologic endoscopic surgery and obstetric safety.

The board also recognized and honored one emeritus trustee:

Eric Schmidt is the former CEO and executive chairman of Google and the current CEO of Relativity Space, an aerospace manufacturing company. He was also the executive chairman of Google's parent company, Alphabet Inc., and served as its technical advisor.

###

About the Mayo Clinic Board of Trustees 
The Mayo Clinic Board of Trustees, a group of public representatives and Mayo Clinic physicians and administrators, is responsible for patient care, medical education and research at Mayo Clinic in Arizona, Florida and Minnesota, as well as Mayo Clinic Health System, a network of clinics and hospitals serving communities in Minnesota and Wisconsin.

Media contact:

Andrea Kalmanovitz, Mayo Clinic Communications, newsbureau@mayo.edu

END

ELSE PRESS RELEASES FROM THIS DATE:

NYU named “research powerhouse” in new analysis

2026-02-26

New York University is recognized as one of the 70 top research institutions consistently home to the world’s most-cited researchers over the past five years. The analysis of “research powerhouses,” led by the analytics company Clarivate, demonstrates where research impact is most concentrated. Since 2001, Clarivate has identified “highly cited researchers”—a group of scientists and social scientists whose research published over the last decade has demonstrated ...

New polymer materials may offer breakthrough solution for hard-to-remove PFAS in water

2026-02-26

Scientists are developing a new generation of polymer-based materials that could dramatically improve the removal of persistent “forever chemicals” from drinking water, according to a new review synthesizing recent advances in environmental remediation research. Per- and polyfluoroalkyl substances, known as PFAS, are a large class of human-made chemicals used in products ranging from firefighting foams to nonstick cookware and textiles. Their extreme stability allows them to persist in the environment and accumulate in water supplies, raising growing concerns about long-term ...

Biochar can either curb or boost greenhouse gas emissions depending on soil conditions, new study finds

2026-02-26

A new study reveals that biochar, a carbon rich material increasingly promoted for climate friendly agriculture, can have sharply different effects on greenhouse gas emissions depending on soil type and land use. The research shows that while biochar can significantly reduce nitrous oxide emissions in acidic upland soils, it may unexpectedly increase emissions in flooded rice paddies. Nitrous oxide is one of the most potent greenhouse gases, with a warming effect far greater than carbon dioxide over the long term. Agricultural soils are a major source of these emissions, making mitigation strategies critical for climate and food system sustainability. In the ...

Nanobiochar emerges as a next generation solution for cleaner water, healthier soils, and resilient ecosystems

2026-02-26

A new scientific review points to nanobiochar, an engineered carbon material derived from biomass, as a promising solution for some of the world’s most pressing environmental challenges. By shrinking conventional biochar to the nanoscale, researchers have created a material with dramatically increased surface area, reactivity, and environmental functionality, opening new possibilities for soil improvement, water treatment, and climate resilience. Biochar has long been used to improve soil quality and capture carbon, but the new analysis shows that nanoscale versions ...

Study finds more parents saying ‘No’ to vitamin K, putting babies’ brains at risk

2026-02-26

EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, THURSDAY, FEBRUARY 26, 2026 Highlights: A new review of research has found the number of parents refusing vitamin K injections for their newborns is on the rise. Vitamin K is an essential vitamin that is naturally low in newborns. Vitamin K at birth is needed to help blood to clot. It is not a vaccine. Babies who do not receive vitamin K at birth are at a higher risk of life-threatening brain bleeds and long-term disability. While vitamin K refusal remains low, less than 1%, the review found rates of refusal in Minnesota ...

Scientists develop new gut health measure that tracks disease

2026-02-26

Scientists have identified a new way to distinguish healthy guts from diseased ones and track how some illnesses progress by measuring how gut bacteria interact with one another. According to a study published in Science, a collaboration between scientists at Rutgers University, Universidad de Granada in Spain and Princeton University found that healthy and diseased gut microbiomes behave like two distinct ecological states, driven not by individual microbes but by how entire bacterial communities compete and cooperate. “Instead ...

Rice gene discovery could cut fertiliser use while protecting yields

2026-02-26

UNDER EMBARGO UNTIL 19:00 GMT / 14:00 ET THURSDAY 26 FEBRUARY 2026 Rice gene discovery could cut fertiliser use while protecting yields Researchers from the University of Oxford, Nanjing Agricultural University, and Institute of Genetics and Developmental Biology (Chinese Academy of Sciences) have finally identified the master regulator in plants that balances root and shoot growth when nutrients are limited. In field trials, rice plants with an improved version of the gene had yield increases of up to 24%. The breakthrough, published today (26 February) in the prestigious ...

Jumping ‘DNA parasites’ linked to early stages of tumour formation

2026-02-26

A study published today in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilise the cancer genome. Unstable genomes are a fertile playground for cancer evolution, giving malignant cells more opportunities to grow, adapt and evade treatment. The researchers analysed genome sequences from tumours with unusually high activity of LINE-1 (L1) elements, fragments of DNA which copy themselves and paste that copy into other locations within the genome. Previously thought ...

Ultra-sensitive CAR T cells provide potential strategy to treat solid tumors

2026-02-26

Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors. Now, a new form of highly sensitive CAR T cells aims to overcome one of the biggest barriers in solid tumor immunotherapies – the way solid tumors lack a single, widely shared surface target. By engineering an ultra-sensitive receptor capable of detecting even the smallest amounts of the protein CD70, researchers report they were able to eradicate kidney, ovarian, and pancreatic tumors in preclinical models. The findings provide a potential strategy to treat a broad range of solid tumors. ...

Early Neanderthal-Human interbreeding was strongly sex biased

2026-02-26

When Neanderthals and ancient modern humans interbred, the pairings were mostly between male Neanderthals and female humans. This finding helps explain why Neanderthal ancestry present in most humans is unevenly distributed. Anatomically modern humans carry low levels of Neanderthal ancestry, but it is not evenly shared. When the genomes of Neanderthals and modern humans are compared, striking gaps known as “Neanderthal deserts” are revealed. These are large stretches of DNA in modern humans where Neanderthal genetic contributions are unusually rare. Such deserts appear across several chromosomes and are especially prominent on the X chromosome. According to Alexander Platt and ...

Eric Moore, M.D., elected to Mayo Clinic Board of Trustees

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: